Australia's Genetic Signature hits record low on lower quarterly sales

Genetic Signatures

20/01/2026 04:55

** Shares of Genetic Signatures GSS.AX down as much as 4.6% at its record low level of A$0.21

** The molecular diagnostics firm posts Q2 FY26, sales of A$3.3 million ($2.22 million), down from A$3.8 million a year ago

** About 422,306 shares change hands, 3.7x 30-day average

** Stock fell 60.3% in 2025

($1 = 1.4857 Australian dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))